Sinopharm Consistent 2026 H1 Revenue RMB 36.266 Billion, Net Profit RMB 606 Million, Down 1.44% and 8.97%
Sinopharm Consistent's 2026 interim report shows revenue of RMB 36.266 billion, down 1.44% year on year, and net profit attributable to shareholders of RMB 606 million, down 8.97%. Distribution revenue fell 0.91% to RMB 26.539 billion, while Guoda Pharmacy revenue declined 2.4% to RMB 10.227 billion, with narrowing decline. Investment income from key associates dropped 30.43% due to geopolitical and policy factors.
Sinopharm Consistent disclosed its 2026 semi-annual report. In the first half of 2026, the company achieved operating revenue of RMB 36.266 billion, down 1.44% year on year; net profit attributable to shareholders of the listed company was RMB 606 million, down 8.97%; basic earnings per share were RMB 0.99.
By segment, the distribution segment achieved operating revenue of RMB 26.539 billion, down 0.91% year on year; Guoda Pharmacy achieved operating revenue of RMB 10.227 billion, down 2.4%, with the decline narrowing. Affected by industry policy adjustments, intensified market competition, and other factors, Guoda Pharmacy's sales revenue declined slightly. Combined with changes in sales structure, the proportion of high-margin products decreased, reducing gross profit and leading to lower profit.
In addition, the company's key associates saw performance declines due to international geopolitical factors, pharmaceutical industry policies, and market supply-demand dynamics, with corresponding investment income falling 30.43% year on year.
Why this event matters
The event has a measured impact on 3 industrys. The strongest current signal is negative for General Hospitals, with intensity 60/100 and 80% confidence over a short term horizon.
General Hospitals
- Direction
- negative
- Intensity
- 60
- Confidence
- 80%
- Horizon
- Short term
Pharmaceutical R&D Services
- Direction
- negative
- Intensity
- 50
- Confidence
- 70%
- Horizon
- Short term
Medical Consumables
- Direction
- negative
- Intensity
- 40
- Confidence
- 60%
- Horizon
- Short term
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.